ABT-355 [choline fenofibrate] reverse cholesterol transport (RCT) study

Trial Profile

ABT-355 [choline fenofibrate] reverse cholesterol transport (RCT) study

Phase of Trial: Phase I/II

Latest Information Update: 25 Mar 2011

At a glance

  • Drugs Choline fenofibrate (Primary)
  • Indications Dyslipidaemias
  • Focus Therapeutic Use
  • Most Recent Events

    • 14 Oct 2009 Actual end date (May 2009) added as reported by ClinicalTrials.gov.
    • 14 Oct 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 02 Jun 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top